8.3 Hormonal Therapy
4 min read•june 18, 2024
is a powerful weapon against hormone-dependent cancers. It works by blocking hormone production, interfering with , or inducing receptor degradation. These treatments target breast, prostate, endometrial, and thyroid cancers.
Nurses play a crucial role in managing hormonal therapies. They educate patients on adherence, side effects, and lifestyle changes. Monitoring treatment response, administering medications, and collaborating with the healthcare team are key nursing responsibilities in hormonal cancer treatment.
Hormonal Therapy in Cancer Treatment
Key features of hormonal therapy drugs
Top images from around the web for Key features of hormonal therapy drugs
Hormone Therapy - Free of Charge Creative Commons Medical image View original
Is this image relevant?
Frontiers | To block or not to block—hormonal signaling in the treatment of cancers View original
Is this image relevant?
Frontiers | Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced ... View original
Is this image relevant?
Hormone Therapy - Free of Charge Creative Commons Medical image View original
Is this image relevant?
Frontiers | To block or not to block—hormonal signaling in the treatment of cancers View original
Is this image relevant?
1 of 3
Top images from around the web for Key features of hormonal therapy drugs
Hormone Therapy - Free of Charge Creative Commons Medical image View original
Is this image relevant?
Frontiers | To block or not to block—hormonal signaling in the treatment of cancers View original
Is this image relevant?
Frontiers | Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced ... View original
Is this image relevant?
Hormone Therapy - Free of Charge Creative Commons Medical image View original
Is this image relevant?
Frontiers | To block or not to block—hormonal signaling in the treatment of cancers View original
Is this image relevant?
1 of 3
- targets hormone-dependent cancers ()
- Breast, prostate, endometrial, and thyroid cancers are commonly treated with hormonal therapy
- Mechanisms of action:
- Blocking hormone production
- (AIs) block estrogen synthesis by inhibiting the aromatase enzyme (, )
- agonists/antagonists suppress testosterone production by inhibiting the (, )
- Interfering with hormone receptor binding
- () like bind to estrogen receptors and block estrogen signaling in breast tissue
- like and compete with androgens for binding to androgen receptors in prostate cancer cells
- Inducing hormone receptor degradation
- () like bind to estrogen receptors and promote their degradation, reducing estrogen signaling
- Blocking hormone production
Clinical applications of hormonal therapies
- Breast cancer
- Adjuvant therapy for hormone receptor-positive (HR+) early-stage breast cancer to reduce recurrence risk
- Treatment for metastatic HR+ breast cancer to slow disease progression and improve survival
- Potential risks: hot flashes, joint pain, , increased risk of endometrial cancer with tamoxifen use
- Prostate cancer
- Treatment for advanced or metastatic prostate cancer to slow disease progression and alleviate symptoms
- Potential risks: hot flashes, sexual dysfunction, , cardiovascular events
- Endometrial cancer
- Treatment for advanced or recurrent endometrial cancer to control tumor growth and manage symptoms
- Potential risks: , , uterine cancer with tamoxifen use
- Thyroid cancer
- Suppression of (TSH) in differentiated thyroid cancer to reduce the risk of recurrence
- Potential risks: , osteoporosis,
Endocrine System and Hormonal Therapy
- The plays a crucial role in hormone production and regulation
- , such as estrogen and testosterone, are primary targets for hormonal therapy
- Receptor binding is a key mechanism in hormone action and is often targeted by hormonal therapies
- can develop over time, reducing the effectiveness of hormonal treatments
- may be exacerbated or induced by certain hormonal therapies
Nursing considerations for hormonal therapy
- Patient education
- Emphasize the importance of adherence to the treatment plan for optimal outcomes
- Discuss potential side effects and management strategies to minimize discomfort and improve quality of life
- Monitoring
- Assess for treatment response and disease progression through regular clinical assessments and imaging studies
- Monitor for adverse effects, such as hot flashes, joint pain, and mood changes, and implement appropriate interventions
- Perform regular bone density scans to detect osteoporosis and initiate preventive or treatment measures as needed
- Medication administration
- Ensure proper dosing and scheduling of hormonal therapy drugs to maintain therapeutic levels and minimize side effects
- Administer injectable medications (e.g., ) as prescribed, providing patient education on self-injection techniques when appropriate
- Collaboration with the healthcare team
- Communicate patient concerns and treatment-related issues to the oncologist to ensure timely management and adjustments to the treatment plan
- Coordinate care with other specialists (e.g., endocrinologists, gynecologists) as needed to address specific hormone-related concerns or complications
Patient education for hormonal treatment
- Pre-treatment education
- Explain the purpose and expected outcomes of hormonal therapy, emphasizing its role in controlling cancer growth and improving prognosis
- Discuss the treatment schedule and duration, including the importance of long-term adherence for optimal results
- Address potential side effects and their management, providing practical tips and resources for coping with common issues like hot flashes and joint pain
- Ongoing education and support
- Provide written materials and resources for reference, ensuring patients have access to reliable information throughout their treatment journey
- Encourage patients to report any new or worsening symptoms to the healthcare team promptly for early intervention and management
- Offer emotional support and referrals to support groups or counseling services to help patients cope with the psychological impact of cancer and its treatment
- Lifestyle modifications
- Encourage a balanced diet and regular exercise to maintain bone health, manage weight, and promote overall well-being during treatment
- Discuss strategies for managing hot flashes, such as wearing layered clothing, maintaining cool environments, and practicing relaxation techniques
- Address sexual health concerns and offer resources or referrals to specialists or counselors as needed to maintain intimacy and relationships
- Follow-up care
- Emphasize the importance of regular check-ups and monitoring to detect any signs of disease recurrence or progression early
- Educate patients on signs and symptoms of disease recurrence or progression, such as new lumps, pain, or changes in bodily functions
- Encourage open communication with the healthcare team regarding any concerns or questions to ensure prompt attention and personalized care throughout the cancer journey
Key Terms to Review (44)
Anastrozole: Anastrozole is a nonsteroidal aromatase inhibitor used in the treatment of hormone-receptor positive breast cancer in postmenopausal women. It works by blocking the aromatase enzyme, which is responsible for the conversion of androgens to estrogens, thereby reducing estrogen levels and slowing the growth of estrogen-dependent tumors.
Antiandrogens: Antiandrogens are a class of drugs that block the effects of androgens, the male sex hormones, in the body. They work by interfering with the binding of androgens to their receptors, thereby reducing the physiological responses associated with androgen activity.
Antiestrogens: Antiestrogens are a class of drugs that block the effects of estrogen in the body, commonly used in the treatment of hormone-sensitive cancers such as breast cancer. They work by either binding to estrogen receptors or decreasing estrogen production.
Arimadex: Arimidex (anastrozole) is an oral medication used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by inhibiting the enzyme aromatase, which decreases estrogen production.
Aromasin: Aromasin, also known as Exemestane, is an oral medication used to treat hormone-receptor-positive breast cancer. It works by inhibiting the enzyme aromatase, which reduces estrogen levels in the body.
Aromatase Inhibitors: Aromatase inhibitors are a class of medications that work by blocking the enzyme aromatase, which is responsible for the production of estrogen in the body. This makes them an important tool in the hormonal therapy of certain types of cancer, particularly breast cancer.
Atrial Fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. It occurs when the upper chambers of the heart (the atria) quiver instead of beating effectively, leading to an irregular and sometimes rapid heartbeat.
Atrial fibrillation with rapid ventricular response: Atrial fibrillation with rapid ventricular response (AFib with RVR) is a condition where the atria beat irregularly and frequently, leading to a fast heart rate in the ventricles. This can result in poor blood flow and increased risk of stroke.
Bicalutamide: Bicalutamide is a nonsteroidal antiandrogen medication primarily used in the treatment of prostate cancer. It works by blocking the action of the male hormone testosterone, which can fuel the growth of prostate cancer cells.
Casodex: Casodex, also known as bicalutamide, is a non-steroidal anti-androgen medication used in the treatment of prostate cancer. It works by blocking the action of androgens (male hormones) to slow down the growth of cancer cells.
Endocrine Resistance: Endocrine resistance refers to the reduced responsiveness or insensitivity of target tissues to the normal physiological actions of endocrine hormones. This phenomenon can occur in various endocrine-related diseases and conditions, significantly impacting the effectiveness of hormonal therapies.
Endocrine System: The endocrine system is a complex network of glands and hormones that regulate and coordinate many of the body's functions, including growth, metabolism, sexual function, and mood. It plays a crucial role in maintaining homeostasis and ensuring the proper functioning of various physiological processes.
Endometrial Hyperplasia: Endometrial hyperplasia is a condition where the lining of the uterus (endometrium) becomes abnormally thickened. This can be a precursor to uterine cancer, and is often associated with excess estrogen exposure without adequate progesterone balance.
Eulexin: Eulexin is a nonsteroidal antiandrogen medication used primarily in the treatment of prostate cancer. It works by blocking the effect of androgens (male hormones) to slow the growth of cancer cells.
Exemestane: Exemestane is an oral medication that inhibits the enzyme aromatase, which is responsible for converting androgens into estrogens. It is primarily used in the treatment of estrogen receptor-positive breast cancer in postmenopausal women.
Faslodex: Faslodex, also known as fulvestrant, is a hormonal therapy drug used to treat hormone receptor-positive metastatic breast cancer. It works by blocking and degrading estrogen receptors in breast cancer cells.
Flutamide: Flutamide is a synthetic nonsteroidal antiandrogen medication used primarily in the treatment of prostate cancer. It works by blocking the action of the male hormone androgen, which can fuel the growth of prostate cancer cells.
Fulvestrant: Fulvestrant is a selective estrogen receptor downregulator (SERD) used in the treatment of hormone receptor-positive, advanced breast cancer. It works by binding to and degrading estrogen receptors, thereby reducing the growth-promoting effects of estrogen on breast cancer cells.
GnRH Agonists: GnRH agonists are a class of drugs that mimic the action of the naturally occurring gonadotropin-releasing hormone (GnRH) in the body. They are primarily used in the context of hormonal therapy and masculinizing hormonal therapy to regulate the production and release of sex hormones, such as testosterone and estrogen.
GnRH Antagonists: GnRH antagonists are a class of medications that work by directly blocking the action of gonadotropin-releasing hormone (GnRH) in the body. This disruption in the GnRH signaling pathway leads to a reduction in the production and release of the reproductive hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), from the pituitary gland.
Gonadotropin-releasing hormone: Gonadotropin-releasing hormone (GnRH) is a hormone produced by the hypothalamus in the brain that regulates the production and release of the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), from the anterior pituitary gland. This hormone plays a crucial role in the functioning of the male and female reproductive systems.
Gonadotropin-releasing hormone (GnRH): Gonadotropin-releasing hormone (GnRH) is a peptide hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary gland. It plays a critical role in regulating reproductive function.
Goserelin: Goserelin is a synthetic hormone that acts as a gonadotropin-releasing hormone (GnRH) agonist. It is primarily used in the context of hormonal therapy and masculinizing hormonal therapy to manage various medical conditions.
Hormonal therapy: Hormonal therapy involves using medications or surgical procedures to block, add, or remove hormones to slow or stop the growth of hormone-sensitive cancers. It is often used in cancers that rely on hormones for their growth, such as breast and prostate cancer.
Hormonal Therapy: Hormonal therapy is a medical treatment that involves the use of synthetic or natural hormones to manage various health conditions. It aims to restore hormonal balance, regulate bodily functions, and alleviate symptoms associated with hormonal imbalances.
Hormone-sensitive Cancers: Hormone-sensitive cancers are a group of cancers that are influenced by the presence or absence of certain hormones in the body. These types of cancers often respond to hormonal therapy, which aims to manipulate the hormonal environment to inhibit cancer growth and progression.
Hyperthyroidism: Hyperthyroidism is a condition in which the thyroid gland produces an excessive amount of thyroid hormones, leading to an overactive metabolism. This imbalance can have significant impacts on various bodily functions and is an important consideration in the context of hormonal therapy, potassium channel blockers, and thyroid-related disorders.
Hypothalamic-pituitary-gonadal axis: The hypothalamic-pituitary-gonadal (HPG) axis is a complex hormonal system that regulates reproductive function and development. It involves the coordinated interactions between the hypothalamus, pituitary gland, and gonads (testes or ovaries) to maintain hormonal homeostasis and facilitate reproduction.
Letrozole: Letrozole is a non-steroidal aromatase inhibitor used in the treatment of hormone-receptor positive breast cancer. It works by blocking the enzyme aromatase, which is responsible for the conversion of androgens to estrogens, thereby reducing estrogen levels in the body.
Leuprolide: Leuprolide is a synthetic hormone agonist that acts on the pituitary gland to suppress the production of testosterone and estrogen, making it a valuable therapeutic agent in the management of hormone-sensitive cancers and conditions related to hormonal imbalances.
Menopausal Symptoms: Menopausal symptoms refer to the various physical and psychological changes that occur during the transition to menopause, the permanent cessation of a woman's menstrual cycles. These symptoms are directly related to the hormonal fluctuations and imbalances that occur as a woman's ovaries gradually produce less estrogen and progesterone.
Neuroendocrine system: The neuroendocrine system is a complex network of interactions between the nervous system and the endocrine glands, primarily involving the hypothalamus and pituitary gland. It regulates various physiological processes such as stress response, growth, and metabolism.
Nolvadex: Nolvadex, also known as tamoxifen, is a selective estrogen receptor modulator (SERM) commonly used in the treatment of breast cancer. It works by blocking estrogen receptors on breast cancer cells, which inhibits their growth.
Osteoporosis: Osteoporosis is a condition characterized by weakened bones and an increased risk of fractures. It results from an imbalance between bone resorption and bone formation.
Osteoporosis: Osteoporosis is a progressive bone disease characterized by a decrease in bone mass and density, leading to an increased risk of fractures. This condition affects the structural integrity of bones, making them more fragile and susceptible to breaks, especially in the hips, spine, and wrists.
Receptor Binding: Receptor binding is the process by which a molecule, such as a drug or hormone, binds to a specific receptor on the surface or within a cell, triggering a physiological response. This interaction between the ligand and the receptor is a fundamental mechanism underlying the effects of various pharmacological agents and endogenous signaling molecules.
Selective Estrogen Receptor Degraders: Selective estrogen receptor degraders (SERDs) are a class of pharmaceutical compounds that selectively bind to and induce the degradation of estrogen receptors (ERs) in target tissues. This process leads to a reduction in the overall ER levels, thereby inhibiting the proliferative effects of estrogen signaling, which is a key driver of certain hormone-sensitive cancers.
Selective Estrogen Receptor Modulators: Selective estrogen receptor modulators (SERMs) are a class of drugs that act as agonists or antagonists on estrogen receptors in different tissues. They exhibit tissue-selective estrogenic effects, meaning they can mimic or block the actions of estrogen depending on the target organ.
SERDs: SERDs, or Selective Estrogen Receptor Degraders, are a class of drugs used in the hormonal therapy of certain types of breast cancer. These compounds work by binding to and promoting the degradation of the estrogen receptor, thereby reducing the activity of estrogen signaling in cancer cells.
SERMs: SERMs, or Selective Estrogen Receptor Modulators, are a class of drugs that act on estrogen receptors in the body. They can have both agonistic (activating) and antagonistic (blocking) effects on estrogen, depending on the specific tissue or organ. SERMs are primarily used in the context of hormonal therapy to manage conditions related to estrogen imbalance.
Steroid Hormones: Steroid hormones are a class of lipid-soluble signaling molecules derived from cholesterol that play crucial roles in various physiological processes within the body. They are produced primarily by the endocrine glands, including the adrenal cortex, gonads, and placenta, and exert their effects on target tissues by binding to specific intracellular receptors.
Tamoxifen: Tamoxifen is a selective estrogen receptor modulator (SERM) that is primarily used in the treatment and prevention of certain types of breast cancer. It works by blocking the effects of estrogen in breast tissue, thereby inhibiting the growth and spread of hormone-sensitive cancer cells.
Thyroid-stimulating hormone: Thyroid-stimulating hormone (TSH) is a hormone produced by the pituitary gland that regulates the function of the thyroid gland. It plays a crucial role in maintaining proper thyroid hormone levels and overall thyroid function in the body.
Venous Thromboembolism: Venous thromboembolism (VTE) is a condition where a blood clot forms in a vein, often in the deep veins of the leg or pelvis, and can potentially travel to the lungs, causing a pulmonary embolism. VTE is a serious medical condition that can have significant implications, especially in the context of hormonal therapy, bisphosphonates, calcium preparations, vitamin D, and estrogen receptor modulators.